|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
LT2814844T
(lt)
|
2012-02-15 |
2017-10-25 |
Novo Nordisk A/S |
Antikūnai, kurie jungiasi ir blokuoja ekspresuotą ant mieloidinių ląstelių inicijuojantį receptorių 1 (trem-1)
|
|
LT2814842T
(lt)
|
2012-02-15 |
2018-11-12 |
Novo Nordisk A/S |
Antikūnai, kurie suriša peptidoglikaną atpažįstantį baltymą 1
|
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
|
WO2014182927A1
(en)
*
|
2013-05-08 |
2014-11-13 |
Rutgers, The State University Of New Jersey |
Near infrared label and methods of use thereof
|
|
US9700638B2
(en)
|
2012-05-08 |
2017-07-11 |
Rutgers, The State University Of New Jersey |
Near infrared label and methods of use thereof
|
|
BR112015018899B1
(pt)
*
|
2013-02-08 |
2023-09-26 |
Novartis Ag |
Imunoconjugados, composição farmacêutica, anticorpos igg modificados ou fragmentos de anticorpo modificados dos mesmos e seu método de produção, e célula hospedeira
|
|
RU2652880C2
(ru)
*
|
2013-04-07 |
2018-05-03 |
Дженрикс (Шанхай) Байофармасертикал Ко., Лтд. |
Антитело против рецептора эпидермального фактора роста
|
|
SI2991683T1
(sl)
|
2013-05-02 |
2020-01-31 |
Glykos Finland Oy |
Konjugati glikoproteina ali glikana s toksično obremenitvijo
|
|
WO2015031698A1
(en)
|
2013-08-28 |
2015-03-05 |
Stem Centrx, Inc. |
Site-specific antibody conjugation methods and compositions
|
|
IL312865B2
(en)
*
|
2013-09-11 |
2025-06-01 |
Eagle Biologics Inc |
Liquid protein formulations containing viscosity-lowering agents
|
|
US10570204B2
(en)
|
2013-09-26 |
2020-02-25 |
The Medical College Of Wisconsin, Inc. |
Methods for treating hematologic cancers
|
|
PE20160870A1
(es)
|
2013-11-06 |
2016-09-09 |
Abbvie Stemcentrx Llc |
Anticuerpos anti-claudina novedosos y metodos de uso
|
|
KR20160097336A
(ko)
|
2013-12-12 |
2016-08-17 |
스템센트알엑스 인코포레이티드 |
신규 항-ｄｐｅｐ3 항체 및 이의 사용 방법
|
|
ES2716685T3
(es)
|
2014-01-24 |
2019-06-14 |
Dana Farber Cancer Inst Inc |
Moléculas de anticuerpo para PD-1 y usos de las mismas
|
|
DK3099717T3
(da)
|
2014-01-31 |
2019-07-01 |
Novartis Ag |
Antistofmolekyler med tim-3 og anvendelser deraf
|
|
EP4212552B1
(en)
|
2014-01-31 |
2024-11-13 |
Daiichi Sankyo Company, Limited |
Anti-her2 antibody-drug conjugate
|
|
JP6713931B2
(ja)
|
2014-02-11 |
2020-06-24 |
シアトル ジェネティクス，インコーポレイティド |
タンパク質の選択的還元
|
|
KR20170008202A
(ko)
|
2014-02-21 |
2017-01-23 |
애브비 스템센트알엑스 엘엘씨 |
흑색종에 사용하기 위한 항-ｄｌｌ3 항체 및 약물 접합체
|
|
TWI777174B
(zh)
|
2014-03-14 |
2022-09-11 |
瑞士商諾華公司 |
針對lag-3之抗體分子及其用途
|
|
SG11201608309PA
(en)
*
|
2014-04-10 |
2016-11-29 |
Daiichi Sankyo Co Ltd |
Anti-her3 antibody-drug conjugate
|
|
CN106536559B
(zh)
|
2014-07-17 |
2021-04-27 |
诺和诺德股份有限公司 |
定点诱变trem-1抗体以降低黏度
|
|
TW201617368A
(zh)
|
2014-09-05 |
2016-05-16 |
史坦森特瑞斯公司 |
新穎抗ｍｆｉ２抗體及使用方法
|
|
EP3191126B1
(en)
|
2014-09-13 |
2020-05-13 |
Novartis AG |
Combination therapies of alk inhibitors
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
HK1247132A1
(zh)
*
|
2015-01-22 |
2018-09-21 |
Prothena Biosciences Limited |
识别medin的抗体
|
|
GB201506393D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506407D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506394D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506389D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506402D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506399D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
AU2016286898B2
(en)
|
2015-06-29 |
2022-12-08 |
Daiichi Sankyo Company, Limited |
Method for selectively manufacturing antibody-drug conjugate
|
|
KR102726248B1
(ko)
|
2016-07-07 |
2024-11-05 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
항체-애쥬번트 접합체
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
JPWO2018110515A1
(ja)
|
2016-12-12 |
2019-10-24 |
第一三共株式会社 |
抗体−薬物コンジュゲートと免疫チェックポイント阻害剤の組み合わせ
|
|
BR112019012847A2
(pt)
|
2017-01-17 |
2019-12-10 |
Daiichi Sankyo Co Ltd |
anticorpo ou fragmento funcional do anticorpo, polinucleotídeo, vetor de expressão, células hospedeiras, método para produção de um anticorpo de interesse ou de um fragmento funcional do anticorpo e para produção de um conjugado de anticorpo-fármaco, conjugado de anticorpo-fármaco, composição farmacêutica, fármaco antitumoral, e, método de tratamento de um tumor.
|
|
UA125198C2
(uk)
|
2017-02-08 |
2022-01-26 |
Ейдісі Терапьютікс Са |
Кон'югати піролобензодіазепін-антитіло
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
MX2019009372A
(es)
*
|
2017-02-08 |
2019-12-11 |
Pfizer |
Produccion a gran escala para cisteinas de anticuerpo protegidas y no protegidas y su uso en la conjugacion de proteinas terapeuticas.
|
|
BR112019015915A2
(pt)
|
2017-02-28 |
2020-04-07 |
Daiichi Sankyo Co Ltd |
método para o tratamento de câncer de pulmão de células não pequenas resistentes a egfr-tki através da administração do conjugado de anticorpo anti-her3-fármaco
|
|
SI3612537T1
(sl)
|
2017-04-18 |
2022-10-28 |
Medimmune Limited |
Konjugati pirolobenzodiazepina
|
|
WO2018193102A1
(en)
|
2017-04-20 |
2018-10-25 |
Adc Therapeutics Sa |
Combination therapy with an anti-axl antibody-drug conjugate
|
|
TW202542161A
(zh)
|
2017-05-15 |
2025-11-01 |
日商第一三共股份有限公司 |
抗體－藥物結合物及其用途
|
|
JP7145891B2
(ja)
|
2017-06-14 |
2022-10-03 |
アーデーセー セラピューティクス ソシエテ アノニム |
抗ｃｄ１９ ａｄｃを投与するための投与レジメ
|
|
BR112020003003A2
(pt)
|
2017-08-18 |
2020-08-11 |
Medimmune Limited |
conjugados de pirrolobenzodiazepina
|
|
JP7248578B2
(ja)
|
2017-08-31 |
2023-03-29 |
第一三共株式会社 |
抗体－薬物コンジュゲートの新規製造方法
|
|
AU2018327171B2
(en)
|
2017-08-31 |
2023-03-09 |
Daiichi Sankyo Company, Limited |
Improved method for producing antibody-drug conjugate
|
|
CN111417409B
(zh)
|
2017-11-14 |
2022-07-08 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂䓬缀合物
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
TWI790370B
(zh)
|
2018-04-02 |
2023-01-21 |
美商必治妥美雅史谷比公司 |
抗trem-1抗體及其用途
|
|
CN108642176B
(zh)
*
|
2018-04-12 |
2021-11-09 |
江门市中心医院 |
Part1作为乳腺癌诊断、治疗以及预后标志物的应用
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
HUE067382T2
(hu)
|
2018-05-18 |
2024-10-28 |
Daiichi Sankyo Co Ltd |
Anti-MUC1-exatecan antitest-hatóanyag konjugátum
|
|
JP2021525265A
(ja)
*
|
2018-05-25 |
2021-09-24 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ピロロベンゾジアゼピン複合体
|
|
EP3831853A4
(en)
|
2018-07-27 |
2022-06-01 |
Daiichi Sankyo Company, Limited |
ANTIBODY-DRUG CONJUGATE PROTEIN-RECOGNIZING DRUG UNIT
|
|
KR20250172902A
(ko)
|
2018-07-31 |
2025-12-09 |
다이이찌 산쿄 가부시키가이샤 |
항체-약물 콘주게이트 투여에 의한 전이성 뇌종양의 치료
|
|
WO2020059772A1
(ja)
|
2018-09-20 |
2020-03-26 |
第一三共株式会社 |
抗ｈｅｒ３抗体－薬物コンジュゲート投与によるｈｅｒ３変異がんの治療
|
|
MX2021010477A
(es)
|
2019-03-15 |
2021-10-01 |
Medimmune Ltd |
Dimeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento de cancer.
|
|
CA3130794A1
(en)
|
2019-03-15 |
2020-09-24 |
Bolt Biotherapeutics, Inc. |
Immunoconjugates targeting her2
|
|
CN110596387B
(zh)
*
|
2019-09-20 |
2020-06-12 |
四川大学华西医院 |
Cox10自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
|
|
US20230241259A1
(en)
*
|
2020-06-10 |
2023-08-03 |
Memorial Sloan Kettering Cancer Center |
IMAGING COMPOUNDS SELECTIVE FOR NaV1.7
|
|
GB202105186D0
(en)
|
2021-04-12 |
2021-05-26 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
CN117285647A
(zh)
*
|
2022-06-17 |
2023-12-26 |
南京北恒生物科技有限公司 |
靶向ccr8的嵌合抗原受体及其用途
|
|
KR20260020406A
(ko)
|
2023-06-02 |
2026-02-11 |
다이이찌 산쿄 가부시키가이샤 |
항 her3 항체-약물 콘주게이트와 rasg12c 저해제의 조합
|